7.00 pm | 20 May 2013 |  Source: Moneycontrol.com

Divis Laboratories has informed BSE that Prof. C. Ayyanna, Independent Director of the Company has resigned from the Board due to personal reasons and...

3.26 pm | 15 May 2013 |  Source: CNBC-TV18

Parag Doctor of Keynote Capital is bullish on Divis Laboratories, UCO Bank, Zee Entertainment and has recommended buy rating on the stocks, while he m...

11.51 am | 15 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com feels that a new uptrend seems to be starting in Ranbaxy Laboratories....

8.29 am | 15 May 2013 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com has recommended buy rating on Sun Pharma Advanced Research Company, Autoline Industries, Sonata Software and Reliance Co...

11.53 am | 14 May 2013 |  Source: CNBC-TV18

One can take a long position in Divis Laboratories. It is likely to outperform, says Sudarshan Sukhani of s2analytics.com....

11.29 am | 11 May 2013 |  Source: Moneycontrol.com

Divis Laboratories board meeting will be held on May 20, 2013, to consider and approve the audited financial results for the year ended March 31, 2013...

2.27 pm | 30 Apr 2013 |  Source: CNBC-TV18

In CNBC-TV18's popular show Bull's Eye, Nooresh Merani of AMSEC Research shares his trading strategies for the day....

9.39 am | 30 Apr 2013 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

12.39 pm | 29 Apr 2013 |  Source: CNBC-TV18

In CNBC-TV18's popular show Bull's Eye, Nooresh Merani, AMSEC Research shares his trading strategies for the day....

9.02 am | 29 Apr 2013 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

12.12 pm | 18 Apr 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com advised buying Divis Laboratories. According to him, pharmaceutical sector still outperforms....

1.30 pm | 16 Apr 2013 |  Source: Moneycontrol.com

Motilal Oswal has come with its March`13 quarterly earning estimates for healthcare sector. The research firm expects a top line growth of 17.4% YoY a...

7.38 pm | 22 Mar 2013 |  Source: Moneycontrol.com

Nirmal Bang is bullish on Divis Laboratories (DLL) and has recommended buy rating on the stock with a target price of Rs 1276 in its March 22, 2013 re...

6.31 pm | 06 Feb 2013 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Divis Labs and has recommended buy rating on the stock with a target of Rs 1450 in its February 4, 2013 research report....

5.11 pm | 05 Feb 2013 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Divis Labs and has recommended accumulate rating on the stock with a target of Rs 1109 in its February 4, 2013 resea...

3.27 pm | 05 Feb 2013 |  Source: Moneycontrol.com

Dolat Capital is bullish on Divis Labs and has recommended accumulate rating on the stock with a target of Rs 1233 in its February 4, 2013 research re...

2.17 pm | 05 Feb 2013 |  Source: Moneycontrol.com

Divis Laboratories has reported a sales standalone turnover of Rs 534.36 crore and a net profit of Rs 147.24 crore for the quarter ended Dec '12...

1.39 pm | 02 Feb 2013 |  Source: CNBC-TV18

Divis Laboratories has announced its third quarter results. The company's Q3 net profit was up 17% at Rs 144.2 crore versus Rs 122.5 crore, year-on-ye...

3.52 pm | 12 Jan 2013 |  Source: Moneycontrol.com

Nirmal Bang has come out with its earnings estimates for pharmaceutical sector for the quarter ended December 2012. The research firm feels margins of...

11.54 am | 12 Jan 2013 |  Source: Moneycontrol.com

Motilal Oswal has come out with its earnings estimates for pharmaceuticals sector for the quarter ended December 2012. The research firm expects the t...